The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.The article also highlights that the preliminary efficacy results show that ApTOLL significantly reduces mortality and long-term functional dis.
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
BOSTON, Feb. 1, 2021 /PRNewswire/ BIOMODEX®, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered with two of the top medical centers in France and a world-class health system in the United States to develop EVIAS Plus ™ – an innovative training solution for treatment of ischemic stroke.
Ischemic stroke accounts for about 87 percent of all strokes in the U.S. according to the American Stroke Society. This type of stroke is a medical emergency that occurs when a clot forms inside a vessel supplying blood to the brain, where aspiration and mechanical thrombectomy are common treatments. These procedures involve inserting a catheter into an artery in the arm or groin and moving it towards the blood clot under X-ray guidance. The clot may be removed by trapping it in a stent-retriever (mechanical), by sucking out the clot through the cat